Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2019-A02368-49 | Other Identifier | 2019-A02368-49 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Fondation de l'Avenir, France | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Cocaine addiction is a multifactorial disease with important consequences: somatic, psychiatric... The number of applications for treatment for cocaine addiction is gradually increasing from year to year but no conventional treatment is available. New tools such as virtual reality could be used in this treatment. We propose to create a virtual reality program based on the analysis of high-risk relapse situations described by patients. We will then assess the effect of this cybertherapy on patients' relapse time and their desire to use cocaine
In France, according to the Health Barometer 2017, cocaine testing has seen two decades of increases from 1.2% in 1995 to 5.6% in 2017, making it the second most widely used illicit substance. About 5% of cocaine users may become addicted in the first year of use, while 20% will develop long-term addiction. This dependence or substance use disorder is characterized in particular by a loss of control of cocaine use and continued use despite the negative consequences. Another of the central dimensions of this disorder is the craving (irresistible or irrepressible need or desire to consume) which is caused by internal or external stimuli. Craving is the cause of frequent loss of controls and re-consumption.
The treatment of cocaine addictions is generally based on a dual model of pharmacological treatment often aimed at limiting craving and psychotherapeutic treatment in order to alter the emotions and memory associated with cocaine use; for example: relearning product management when it comes to the subject.
In this context, the use of a 3D tool, which allows a gradual and well-detested exposure without confrontation, seems an interesting prospect. Virtual reality therapies have historically been known for treating phobias (fears). In addictions, exposure therapies are done in imagination and rarely with consumer-inducing situations. Since 2000, several researchers have successfully used virtual reality applications in addictions, but there is little data on objective assessments of the effectiveness of cybertherapy in the treatment of cocaine addictions.
All of these elements converge to propose a protocol called "CORVI" to evaluate the effectiveness of virtual reality exposure therapy as the management of patients with cocaine use disorder versus management classic.
The project is based on 3 phases: 1/construction of films that can be used in cybertherapy that reproduce situations in which there are stimuli generating "craving" to cocaine. 2/ Treatment of 2 randomized patient groups with and without cybertherapy (n-20/group) 3/Relapse evaluations at 1.2 and 3 months post-treatment
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| cybertherapy | Experimental | use of cybertherapy (8 sessions) in addition to cognitive behavioral therapy (4 sessions) (pharmacological treatment are note modified) |
|
| Treatment as usual | Other | Treatment as usual is a cognitive behavioral therapy I (4 sessions) (pharmacological treatment are note modified) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Virtual Reality-Enhanced Cognitive Behavioral Therapy (VR-CBT) | Behavioral | use of cybertherapy (8 sessions) in addition to cognitive behavioral therapy (4 sessions) (pharmacological treatment are note modified) |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of relapser patients at 3 months post-intervention | recovery in consumption of cocaine at M3 after intervention | day 90 after intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Craving score | evaluation of craving score (/10) compared to inclusion score | day 30 after intervention |
| Craving score | evaluation of craving score (/10) compared to inclusion score |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Patient with:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Lise Laclautre | Contact | 334.73.754.963 | promo_interne_drci@chu-clermontferrand.fr |
| Name | Affiliation | Role |
|---|---|---|
| Georges Brousse | University Hospital, Clermont-Ferrand | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU Clermont Ferrand | Clermont-Ferrand | Auvergne | 63000 | France |
Not provided
| ID | Term |
|---|---|
| D016739 | Behavior, Addictive |
| D019970 | Cocaine-Related Disorders |
| ID | Term |
|---|---|
| D003192 | Compulsive Behavior |
| D007175 | Impulsive Behavior |
| D001519 | Behavior |
| D019966 | Substance-Related Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Treatment as usual | Behavioral | Treatment as usual is a cognitive behavioral therapy I (4 sessions) (pharmacological treatment are note modified) |
|
| day 90 after intervention |
| Score on the personal efficiency sentiment scale | Evaluation of the score on the personal efficiency sentiment scale | day 30 after intervention |
| Score on the personal efficiency sentiment scale | Evaluation of the score on the personal efficiency sentiment scale | day 90 after intervention |
| Consumption of quantity of cocaine | Evaluation of quantity of cocaine consumed | day 30 after intervention |
| Consumption of quantity of cocaine | Evaluation of quantity of cocaine consumed | day 60 after intervention |
| Consumption of quantity of cocaine | Evaluation of quantity of cocaine consumed | day 90 after intervention |
| Frequency of consumption of cocaine | Evaluation of the frequency of cocaine consumption | day 30 after intervention |
| Frequency of consumption of cocaine | Evaluation of the frequency of cocaine consumption | day 60 after intervention |
| Frequency of consumption of cocaine | Evaluation of the frequency of cocaine consumption | day 90 after intervention |
| Way of consumption of cocaine | Evaluation of the way of cocaine consumption | day 30 after intervention |
| Way of consumption of cocaine | Evaluation of the way of cocaine consumption | day 60 after intervention |
| Way of consumption of cocaine | Evaluation of the way of cocaine consumption | day 90 after intervention |
| amount of cocaine consumed during relapse | Evaluation of cocaine amount consumed during relapse | day 30 after intervention |
| amount of cocaine consumed during relapse | Evaluation of cocaine amount consumed during relapse | day 90 after intervention |
| Frequence of cocaine consumed during relapse | Evaluation of cocaine frequence consumption during relapse | day 30 after intervention |
| Frequence of cocaine consumed during relapse | Evaluation of cocaine frequence consumption during relapse | day 90 after intervention |
| Percentage of relapser patients | recovery in relapser patients at M1 after intervention | day 30 after intervention |
| Duration of abstinence | recovery of abstinence duration | day 30 after intervention |
| Duration of abstinence | recovery of abstinence duration | day 60 after intervention |
| Duration of abstinence | recovery of abstinence duration | day 90 after intervention |
| D064419 |
| Chemically-Induced Disorders |
| D001523 | Mental Disorders |